Design Therapeutics, Inc.
DSGN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001807120
No open-market purchases or sales by Design Therapeutics, Inc. insiders were filed in the last 90 days; 136 institutions reported holding it in 13F filings for Q2 2026, worth $626.4M in total; no superinvestor holds it.
Q1 2025 vs. Q4 2024
How the institutions holding Design Therapeutics, Inc. changed between Q4 2024 and Q1 2025.
All holders in Q1 2025All holders in Q4 2024
| Measure | Q4 2024 | Of which not filed for Q1 2025 | Q1 2025 | Change |
|---|---|---|---|---|
| Holders | 95 | 1 | 98 | +4 |
| Shares | 33.5M | 158.0K | 34.5M | +1.16M (+3.5%) |
| Value | $206.5M | $974.9K | $133.0M | −$72.5M (−35.3%) |
1 institution that held it in Q4 2024 haven't filed for Q1 2025 yet. Not filing isn't selling, so the changes leave them out.
New holders (14)
Institutions that held Design Therapeutics, Inc. at the end of Q1 2025 but not at the end of Q4 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Kynam Capital Management, LP | 904,017 | $3.49M | 0.30% |
| Woodline Partners LP | 645,694 | $2.49M | 0.02% |
| Nuveen, LLC | 147,228 | $568.3K | 0.00% |
| Wellington Management Group LLP | 141,519 | $546.3K | 0.00% |
| Millennium Management LLC | 87,988 | $339.6K | 0.00% |
| Lynx1 Capital Management LP | 65,954 | $254.6K | 0.09% |
| State of Wisconsin Investment Board | 21,962 | $84.8K | 0.00% |
| Jane Street Group, LLC | 18,125 | $70.0K | 0.00% |
| Velan Capital Investment Management LP | 14,000 | $54.0K | 0.06% |
| Zurcher Kantonalbank (Zurich Cantonalbank) | 2,165 | $8.36K | 0.00% |
| Coldstream Capital Management Inc | 535 | $2.07K | 0.00% |
| Daiwa Securities Group Inc. | 350 | $1.00K | 0.00% |
| EverSource Wealth Advisors, LLC | 31 | $120 | 0.00% |
| Skopos Labs, Inc. | 19 | $74 | 0.00% |
Sold out (10)
Institutions that held Design Therapeutics, Inc. at the end of Q4 2024 and filed for Q1 2025 without it.
| Institution | Shares, Q4 2024 | Value, Q4 2024 |
|---|---|---|
| EcoR1 Capital, LLC | 426,683 | $2.63M |
| Walleye Capital LLC | 141,127 | $870.8K |
| XTX Topco Ltd | 48,424 | $298.8K |
| Squarepoint Ops LLC | 48,186 | $297.3K |
| PDT Partners, LLC | 36,099 | $222.7K |
| Algert Global LLC | 16,238 | $100.2K |
| Bleakley Financial Group, LLC | 13,266 | $81.9K |
| ProShare Advisors LLC | 11,525 | $71.1K |
| Venturi Wealth Management, LLC | 753 | $4.65K |
| SRS Capital Advisors, Inc. | 143 | $883 |
Not filed for Q1 2025 yet (1)
Institutions that held Design Therapeutics, Inc. at the end of Q4 2024 and haven't filed a 13F for Q1 2025. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2024 | Value, Q4 2024 |
|---|---|---|
| Nuveen Asset Management, LLC | 158,004 | $974.9K |